Soligenix, Inc.
Records under this name other than the patents Soligenix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Showing 1 to 6 of 6 · Back to Soligenix, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,763,963 | Topically active steroids for use in interstitial pulmonary fibrosis Lapsed on the fee record Ended Sep 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 19, 2025 | From the USPTO record |
| US 8,535,650 | Stabilized reverse micelle compositions and uses thereof Term ended Term ended Sep 18, 2025 · From the USPTO record | Term ended | Term ended Sep 18, 2025 | From the USPTO record |
| US 9,168,263 | Topically active steroids for use in interstitial pulmonary fibrosis Lapsed on the fee record Ended Oct 27, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2023 | From the USPTO record |
| US 8,263,582 | Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids Term ended Term ended Mar 15, 2022 · From the USPTO record | Term ended | Term ended Mar 15, 2022 | From the USPTO record |
| US 6,096,731 | Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation Term ended Term ended Sep 10, 2018 · From the USPTO record | Term ended | Term ended Sep 10, 2018 | From the USPTO record |
| US 7,323,471 | Topical azathioprine for the treatment of oral autoimmune diseases Lapsed on the fee record Ended Jan 29, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jan 29, 2012 | From the USPTO record |